Focused Investors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,155,850
| Closed | -$80.7M | – | 24 |
|
|
2023
Q3 | $80.7M | Sell |
1,155,850
-18,200
| -2% | -$1.29M | 2.87% | 19 |
|
|
2023
Q2 | $81.2M | Sell |
1,174,050
-5,600
| -0.5% | -$398K | 2.72% | 20 |
|
|
2023
Q1 | $87.7M | Sell |
1,179,650
-55,200
| -4% | -$4.63M | 3.02% | 18 |
|
|
2022
Q4 | $115M | Sell |
1,234,850
-5,300
| -0.4% | -$511K | 3.71% | 15 |
|
|
2022
Q3 | $118M | Sell |
1,240,150
-28,750
| -2% | -$2.85M | 4.24% | 11 |
|
|
2022
Q2 | $118M | Sell |
1,268,900
-1,500
| -0.1% | -$146K | 4.04% | 11 |
|
|
2022
Q1 | $129M | Sell |
1,270,400
-35,700
| -3% | -$3.75M | 4.09% | 11 |
|
|
2021
Q4 | $135M | Buy |
1,306,100
+5,300
| +0.4% | +$490K | 4.12% | 8 |
|
|
2021
Q3 | $110M | Buy |
1,300,800
+50,300
| +4% | +$4.21M | 3.68% | 11 |
|
|
2021
Q2 | $104M | Buy |
1,250,500
+479,500
| +62% | +$39.3M | 3.32% | 15 |
|
|
2021
Q1 | $58M | Sell |
771,000
-35,200
| -4% | -$2.56M | 2.01% | 23 |
|
|
2020
Q4 | $55.1M | Sell |
806,200
-4,900
| -0.6% | -$319K | 1.99% | 23 |
|
|
2020
Q3 | $47.4M | Sell |
811,100
-22,100
| -3% | -$1.38M | 1.94% | 23 |
|
|
2020
Q2 | $54.1M | Sell |
833,200
-5,900
| -0.7% | -$372K | 2.43% | 19 |
|
|
2020
Q1 | $49.8M | Buy |
839,100
+14,600
| +2% | +$975K | 2.48% | 18 |
|
|
2019
Q4 | $61.3M | Sell |
824,500
-27,900
| -3% | -$1.96M | 2.43% | 19 |
|
|
2019
Q3 | $53.8M | Sell |
852,400
-869,072
| -50% | -$51.5M | 2.36% | 20 |
|
|
2019
Q2 | $93.8M | Sell |
1,721,472
-50,600
| -3% | -$2.72M | 4.11% | 14 |
|
|
2019
Q1 | $95.6M | Sell |
1,772,072
-64,175
| -3% | -$3.96M | 4.18% | 13 |
|
|
2018
Q4 | $120M | Buy |
1,836,247
+260,147
| +17% | +$19.4M | 5.52% | 7 |
|
|
2018
Q3 | $124M | Sell |
1,576,100
-5,400
| -0.3% | -$386K | 4.88% | 9 |
|
|
2018
Q2 | $102M | Buy |
1,581,500
+5,600
| +0.4% | +$369K | 4.36% | 12 |
|
|
2018
Q1 | $98M | Sell |
1,575,900
-46,800
| -3% | -$3.36M | 4.29% | 15 |
|
|
2017
Q4 | $118M | Sell |
1,622,700
-40,200
| -2% | -$2.92M | 4.78% | 10 |
|
|
2017
Q3 | $135M | Sell |
1,662,900
-49,400
| -3% | -$3.91M | 5.74% | 3 |
|
|
2017
Q2 | $138M | Sell |
1,712,300
-408,400
| -19% | -$32.2M | 5.85% | 3 |
|
|
2017
Q1 | $166M | Buy |
2,120,700
+349,500
| +20% | +$27.9M | 6.01% | 2 |
|
|
2016
Q4 | $140M | Sell |
1,771,200
-18,100
| -1% | -$1.46M | 5.31% | 7 |
|
|
2016
Q3 | $159M | Buy |
1,789,300
+181,200
| +11% | +$17.1M | 6.32% | 1 |
|
|
2016
Q2 | $154M | Sell |
1,608,100
-27,400
| -2% | -$2.73M | 6.06% | 3 |
|
|
2016
Q1 | $170M | Sell |
1,635,500
-50,900
| -3% | -$4.95M | 6.52% | 3 |
|
|
2015
Q4 | $165M | Sell |
1,686,400
-131,400
| -7% | -$12.9M | 6.36% | 2 |
|
|
2015
Q3 | $175M | Sell |
1,817,800
-34,000
| -2% | -$3.57M | 6.42% | 3 |
|
|
2015
Q2 | $194M | Sell |
1,851,800
-19,100
| -1% | -$1.95M | 6.74% | 1 |
|
|
2015
Q1 | $193M | Buy |
1,870,900
+38,300
| +2% | +$3.88M | 6.69% | 3 |
|
|
2014
Q4 | $176M | Sell |
1,832,600
-116,200
| -6% | -$10.2M | 6.39% | 2 |
|
|
2014
Q3 | $155M | Sell |
1,948,800
-12,100
| -0.6% | -$954K | 5.71% | 5 |
|
|
2014
Q2 | $148M | Sell |
1,960,900
-10,100
| -0.5% | -$763K | 5.55% | 6 |
|
|
2014
Q1 | $148M | Buy |
1,971,000
+77,800
| +4% | +$5.5M | 5.84% | 6 |
|
|
2013
Q4 | $135M | Buy |
1,893,200
+1,700
| +0.1% | +$109K | 5.31% | 7 |
|
|
2013
Q3 | $107M | Buy |
1,891,500
+92,100
| +5% | +$5.49M | 4.61% | 10 |
|
|
2013
Q2 | $103M | Buy |
+1,799,400
| New | +$104M | 4.47% | 10 |
|
Other funds holding CVS
Focused Investors's CVS Position: Q4 2023 in Review
Focused Investors sold out of CVS Health (CVS) in Q4 2023, closing a stake of 1,155,850 shares — an estimated $80.7M sold.
Focused Investors first reported a position in CVS in Q2 2013 and held it in 42 quarters. The position peaked at $194M in Q2 2015. 2,261 funds tracked by Wall St. Rank hold CVS as of Q4 2023.
- Focused Investors reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
- Focused Investors sold 1,155,850 CVS Health shares in Q4 2023, an estimated $80.7M.
- Focused Investors first reported a position in CVS Health in Q2 2013 and held it in 42 quarters.
- Focused Investors's CVS Health position peaked at $194M in Q2 2015.
- 2,261 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.
Based on Focused Investors's 13F filing for Q4 2023, filed 25 Jan 2024.